September 10, 2003 - Volume 25 - Issue 17
pp: 4-77
Subscribe to eTOC


New Medicines in Development for Cancer: Part I

Oncology Times . 25(17):58,61-62, September 10, 2003.

The latest Pharmaceutical Research and Manufacturers of America survey shows a total of 395 cancer-related medicines in the pipeline—70 for lung cancer, 49 for breast cancer, 48 for colorectal cancer, and 44 for prostate cancer, and selected others for kidney, pancreatic, brain, skin, ovarian, and other cancers, as well as those designed to improve the quality of life for people undergoing cancer treatment.


Obesity‐Cancer Link: Public Awareness Rises, But Eating Behavior Changes Little

Eastman, Peggy

Oncology Times . 25(17):6-8, September 10, 2003.

A study by the American Institute for Cancer Research shows that 10% more people now realize that obesity is a risk factor for cancer compared with two years ago, but eating behavior has not changed. Portion control is also problematic, with portion sizes increasing steadily, and Americans unconsciously eating as much as 56% more when served those extra amounts.